Jump directly to content

Fish feed from the forest to salmonids

SALMONAID
SalmonAid

There is an increasing interest from the fish farming industry to develop new feed ingredients to allow for sustainable growth. The SALMONAID project aimed to produce protein-rich ingredients based on side streams from the forest industry, intended to be able to replace both the fishmeal and soy based products currently used in fish feed.

Project leader
Completed
Food
Not applicable
3 years
4 912 000 kr
Division: Division Bioeconomy

Background and aim

Aquaculture meets an increased demand for seafood and is now seen as one of the most promising options for future protein production. But for this to be possible, we need to find solutions to the many challenges in which feed innovation is central. Reducing dependence on fishmeal and fish oil is a high priority for aquaculture in general, especially for example for salmonids that require high protein feed.

The aim of this project was to develop feed for salmonids based on microfungi grown on residual streams from the forest industry. The goal was to speed up the commercialisation, form new collaborations for strengthened international competitiveness for Swedish research and innovation concerning fungi-based fish feed.

Project outcome

Succesful production of meal based on single cell was achieved and feeding trials and showed good results. Life cyle assessment of a feed concept where soy meal is replaced by single cell meal showed environmental advantages. Main results are provided in the one pager below. 

Sara Hornborg

Forskare
+46 10 516 66 96 Read more about Sara
Profile image

Contact Sara

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
9. Industry, innovation and infrastructure
12. Responsible consumption and production
14. Life below water
RISE Processum SLU Domsjö fabriker
One pager main findings
Attach document:

One pager main findings (pdf, 669.7 KB)

Project end date: Food Sekundär områdes navigation:
Circular transition
Biotechnology
Biobased circular processes

Surface Analysis and Surface Design

Surface Analysis and Surface Design
X-ray photoelectron spectroscopy

The Surface Analysis and Surface Design test bed includes laboratories equipped for characterization and optimization of surfaces and surface interactions. We, at RISE, offer complete solutions to support our customer through the entire technological process. Using our broad expertise and a world-leading infrastructure we can help our customers from product idea to market. We can assist all the way in the development process, especially when specific challenges arise, for example to legal requirements or environmental issues.

Laboratory testbeds (LT)
Region Kronoberg Region Stockholm Västra Götaland Region

Viveca Wallqvist

Senior Forskare
+46 10 516 60 76 Read more about Viveca
Profile image

Contact Viveca

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

Mikael Kjellin

Teknologie doktor
+46 10 516 60 56 Read more about Mikael
Profile image

Contact Mikael

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Off
Division: Division Bioeconomy

Examples of areas are:

  • Production and characterization and of nano and micro materials such as graphene, carbon nanotubes and beads. We work on optimization of the nanoparticle dispersion and stabilization. We also develop functional coatings and inks based on nanoparticles. In these areas we have also have expertise in nanosafety research.
  • Modification of surfaces where we can customize particle properties such as repulsion, adhesion, friction, lubrication or charging for applications such as dirt repellency, bonding, powder flow, rolling, fiber processes, medical technology and swallowing.
  • Treatment of surfaces, for instance in areas such as cleaning/washing, painting, polishing or anti-ice treatment.
  • Customer optimization effects, for example in life science where we not only characterize the surfaces using lab instrumentation, but through human panel studies linked to verified models and advanced statistical analysis we can correlate surface analysis data to consumers' experiences.

Our capabilities include technical experts, researchers and professors in surface chemistry, physical chemistry, physics and psychophysics and our well-equipped labs feature advanced equipment for chemical, physical, psychophysical and mechanical characterization of surfaces.

Examples include:

  • X-ray Photoelectron Spectroscopy (XPS), a highly surface sensitive method with straightforward quantification of the surface chemistry at the top 2-10 nanometer of a sample.
  • Atomic Force Microscopy (AFM) with modules for characterizing micro/nano-mechanics, charging and friction in a wide range of temperatures, various atmospheres and liquids, as well as micromanipulation equipment for the functionalization of cantilevers with colloidal probes or fibers.
  • Environmental Scanning Electron Microscopy (ESEM) with energy Dispersive X-ray (EDX) where we can characterize surface structures and do elemental analysis at a wide range of temperatures and humidity.
  • Confocal Raman microscopy where we can make chemical maps of the surface, but also in-depth profile.
  • Laser Diffraction (LD) and Dynamic Light Scattering (DLS) for measuring particle size distribution of particles in powder form or dispersed in liquid, emulsions, liposomes or similar.
  • Contact angle measurements with high-speed camera and picolitre systems that, in addition to measuring static and dynamic contact angles, also enable e.g. measuring on absorbent, repellant or omniphobic surfaces.
  • Infrared Refection Absorption Spectroscopy – IRAS, and Fourier Transformed Infrared Spectroscopy/Attenuated Total Reflection – FTIR-ATR able to give information about the chemical functional groups of the materials.

Our services:

Automotive and transport Energy and Clean Tech Health and Life Sciences Food and agriculture Manufacturing Materials Mining and metal Process industry Pulp, paper and packaging Other
Batteries Bioeconomy Construction Cement and concrete Circular transition Digitalisation Electronics Energy Formulated products Fossil free fuels Packaging Infection control Infrastructure Calibration Chemical processes and products Life cycle analysis Food Pharmaceuticals Lightweight solutions Maritime Pulp and paper Material transition Generic metrology and measurement technology Mobility New therapies Perception Preventive healthcare Production and manufacturing Product safety Risk and safety Built environment Textile Wood technology Surface technology
Not applicable
1963
Bifoga dokument:

Analytical Services (pdf, 1.85 MB)







Biomacromolecules (pdf, 2.3 MB)



Materials and durability Sekundär områdes navigation:
Metrology
Energy and electrification
Biotechnology

Can nanoparticles kill bacteria?

FORMAMP
Nanoparticles of lipids -Cubosomes

Many infection-causing bacteria have developed a strong resistance against commercial available antibiotics and there is a great need for novel innovative treatments. In a sub-project of FORMAMP, antimicrobial peptides were loaded into lipid nanoparticles for protection and delivery of these sensitive bio-molecules.

Project participant and project coordination
Completed
Formulated products Infection control
Not applicable
5 yrs
Division: Division Bioeconomy

Aim

In this project the use of lipid nanoparticles were investigated for delivery and protection of antimicrobial peptides.

Challenge

Due to decades of exposing pathogenic bacteria to non-lethal doses of antibiotics, they have developed a strong resistance against these drug molecules. There is a great need for new and efficient antibacterial drugs and the need will most likely increase in the future.

Solution

The bacterial killing efficiency of the peptide loaded nanoparticles were investigated using in vitro and ex vivo models, as well as the bacterial killing mechanism. Results showed that the nanostructure of the particles strongly affected their bacterial killing efficiency. Particles with a cubic nanostructure (“cubosomes”) were found to be most effective. They protected a protease sensitive antimicrobial peptide (LL-37) from enzymatic degradation, resulting in a significant improved bacterial killing after enzyme exposure, compared to pure peptide.

Effect

A new drug delivery system were designed for antimicrobial peptides, made of lipid nanoparticles, which protected them from enzymatic degradation, resulting in more efficient killing of pathogenic bacteria.

Ulla Elofsson

Assoc. Professor
+46 10 516 60 40 Read more about Ulla
Profile image

Contact Ulla

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
3. Good health and well-being
Project end date: Medtech Sekundär områdes navigation:
Drug development
Composites
Biotechnology

FORMAMP - Innovativ Nanoformulering av Antimikrobiella Peptider

FORMAMP

Kraftiga användning av antibiotika under de senaste årtiondena har lett till att bakterier har utvecklat resistens vilket har orsakat spridning av livshotande sjukdomar. Inom FORMAMP har nanoteknologi i kombination med antimikrobiella peptider ytnytttjats för att utveckla innovativa läkemedelsformuleringar för lokal behandling av infektioner.

Koordinator och forskningspartner
Completed
Formulerade produkter Läkemedel Medicinteknik
Ej tillämpbart
4 år
10.5 MEuro
Division: Division Bioekonomi

Syfte och mål

Det långsiktiga målet för FORMAMP-projektet är att förändra behandlingsstrategierna för infektionssjukdomar och minska spridning av multi-resistenta bakterier.  

Utmaning

Antibiotikaresistens

Lösning

De specifika målen med projektet var att utveckla nya och innovativa formuleringsstrategier för lokal administrering, baserade på kombinationen av nanoteknologiska bärarsystem och antimikrobiella peptider, för behandling av infektionssjukdomar orsakade av bakerier såsom Pseudomonas aeruginosa, MRSA (Methicillin-resistant Staphylococcus aureus) och MTB (Mycobacterium tuberculosis). De kliniska indikationer som har adresserats är hudinfektioner och infektioner i brännsår samt infektioner i lunga såsom cystisk fibros och tuberkulos. Flera av dessa indikationer involverar bildandet av biofilmer, vilket drastiskt försämrar effekten hos tillgängliga behandlingsalternativ. Ett viktigt mål för projektet var därför att utveckla behandlingsstrategier som också tar hänsyn till den problematik som dessa biofilmer orsaker.  

Effekt

Minska spridningen av resistenta bakterier

Ulla Elofsson

Assoc. Professor
+46 10 516 60 40 Read more about Ulla
Profile image

Contact Ulla

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
3.Hälsa och välbefinnande
Project end date: Läkemedelsutveckling Sekundär områdes navigation:
Bioteknik
Komposit
Kemiska processer och produkter

The CO2 micro algae biorefinery

D-Factory
Dunaliella cultivated in demo plant raceway at Monzon, Spain

D-Factory sought to demonstrate the requirements for establishing a sustainable, CO2 algae biorefinery, based on the cultivation and processing of the alga Dunaliella salina. By fractionating the algal biomass into carotenoid isomers, glycerol, and carbohydrate-rich defatted powder, the project aimed to produce multiple bio-based products.

Workpackade leader for "Produkt formulation". Chemical analysis and extraction of proteins and peptides, as well as societal assessment was also performed.
Completed
Bioeconomy Formulated products
4 years
10 083 863 (Euro)
Division: Division Bioeconomy

Aim and goal

The D-Factory aimed to set a world benchmark for a sustainable biorefinery based on biomass from the halophilic microalgae Dunaliella.

Challenge

Dunaliella is currently cultivated commercially for its high β-carotene content. The resulting product is a powder consisting of spray-dried Dunaliella cells and therefore a mixture which largely consists not only of carotenoids but also proteins, carbohydrates, fats and minerals. While the bio-refinery concept to be implemented within this project will go beyond the production of these crude products, it will also result in a number of extracts and extract-rich fractions with different specifications in terms of both compounds and purity. Thus, the challenge of the formulators assessing and evaluating the best possible uses of these extracts, will be not only to test and benchmark the properties of the actual individual components present in Dunaliella but also those of different extract-rich fractions produced as a result of economically viable separation processes.

Solution

Formulation know-how for specific high-value added products applications as well as a good understanding of current possibilities, challenges and limitations of the most important Dunaliella compounds and their properties was the basis for a successful outcome.

Effect

After processing biomass using supercritical CO2 and solvents for 9-cis b-carotene, the natural colorants produced as a by-product are well-suited for food markets that are growing to meet demand from the Lifestyles of Health and Sustainability (LOHAS) demographic and other food sectors, and extracts have been formulated in a variety of ways for use in different beverage-type applications. The defatted powder after processing also shows great promise in tests as a feed additive and also as a protein-rich bulking agent in fish sausages, and the individual starch, polar lipids and protein fractions have been processed as food additives, emulsifiers, and in gluten-free protein-enriched bread.

Karin Persson

Teknisk Doktor
+46 10 516 60 72 Read more about Karin
Profile image

Contact Karin

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
14. Life below water
The consortium covered the whole value chain: Bioprospecting micro algae strains, algae production, harvest, extraction, analysis, formulation, dissemination, financial business case, environmental and societal assesment, process integration and design.
D-Factory brochures and posters
Projekt logo: D-Factory logo Attach document:





D-Factory overview.pdf (pdf, 1.89 MB)





Project end date: Biobased circular processes Sekundär områdes navigation:
Health and life science
Biotechnology
Food
Biobased materials

3D-Bioprinting and additive manufacturing

3D-Bioprinting
3d bioprinting

Through 3D-printing it is possible to build biological structures by combining a biological, or synthetic material, with living cells. 3D-printing can e.g. be used to evaluate biological responses to pharmaceuticals or chemicals and can also be used in the development of future human spare parts. Within the manufacturing process, RISE develops competence and studies the characteristics and functions of 3D-Bioprinting systems.

Laboratory testbeds (LT)
Västra Götaland Region

Patrik Stenlund

Forskare
+46 10 516 58 30 Read more about Patrik
Profile image

Contact Patrik

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Off
Division: Division Bioeconomy

The 3D-printing technology, also known as additive manufacturing, are used to build structures or components layer by layer. When it comes to 3D-Bioprinting, living cells and support materials are combined to build structures similar to living tissues. An interesting aspect is that the printed structures can be used as systems for testing different biological effects, e.g. those of not fully developed pharmaceuticals, and chemicals in general. In the long term it is believed that 3D-Bioprinting may advance the development of transplants that can replace damaged or failing tissues and organs.

At RISE we perform research on new materials and implementations of 3D-Bioprinting within e.g. cancer research. The research projects are done in collaboration with medical industries and clinical research groups. Apart from 3D-Bioprinting, the establishment includes research and development of 3D-printing of a broad variety of materials, with a focus on health technical implementations, where surface modification, material characteristics, modeling, and geometry assurance hold great value.

We offer development of methods and printable materials and functionalize them to suit the specific application. We have a large infrastructure of different printing technologies within the institute. Lastly, we also offer characterization and evaluation in vitro and in vivo.

Health and Life Sciences
Additive manufacturing Life Science Pharmaceuticals
Not applicable
2019
Division (OLD): Division Bioeconomy Medtech Sekundär områdes navigation:
Additive manufacturing
Medtech
Biotechnology
Biobased materials
Drug development

Oil-rich yeast fungi for the production of aviation fuel from sawmill

Aviation fuel from sawmill residues

Low-value residues from Swedish sawmills and the wood industry have the potential to meet most of the demand for bio-based fuel for domestic air traffic. The project will develop technology for the production of biofuel via a sugar platform process using oil-rich yeast fungi and chemical-catalytic processing into aviation fuel.

Project manager and research coordinator
Completed
Region Västernorrland
2020-12-30
5705000
Division: Division Bioeconomy

Björn Alriksson

Affärsutvecklare
+46 10 516 67 53 Read more about Björn
Profile image

Contact Björn

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Project end date: Fossil-free fuels Sekundär områdes navigation:
Biotechnology
Biobased materials
Chemical products and processes

Rapid Bioprocess Development

Biorapid

The printed biosensor projects (two PhDs students) are performed under the umbrella of the Biorapid ITN training project. This EU project is aiming at establishing a pan-European training network that will provide essential training to Early Stage Researchers (ESRs) in methods for rapid biopharmaceutical processes development and monitoring.

Partner in sensor development
Completed
Pharmaceuticals
4 years
49.5 MSek

Aim and goal

The goals of the printed biosensor projects are the design, development and evaluation of printed biosensors for the fast reliable and cost-effective at-line monitoring of bioprocesses, both up- and downstream.

In the first project the ESR will develop electrochemical biosensors for the at-line monitoring of key components (e.g. lactate) of cultivation media.

In the second project the ESR will focus on down-stream detection of the products (e.g. antibodies).

Challenge

Development of sensor able to withstand working conditions (e.g. temperature and environment) and requirements (e.g. concentration of molecules to be detected) associated with monitoring in bioprocesses.

Demonstration that electrochemical low-cost biosensors could replace existing technologies.

Solution

Develop low-cost screen-printed sensors with tailored molecular recognition.

Explore the use of different polymeric coatings and combination of biomolecules to improve sensors stability and to tailor their analytical performance.

Effect

Biorapid project is expected to provide a variety of benefits at different level:

Improving the production of biopharmaceuticals by providing novel sensing tools for more punctual and cost-effective monitoring of the process and of the products.

Consolidating the positioning of the EU in the area of biopharmaceutical production.

Provide to the scientific community novel technical solutions and know-how in the area of bio-production and biopharmaceutical.

Provide the society and pharmaceutical industries with highly trained individuals.

Profile image

Contact Valerio

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
3. Good health and well-being
Project end date: Biotechnology Sekundär områdes navigation:
Printed electronics
Sensors and sensor systems
Health and life science
Chemical products and processes

Transportable demonstration factory for production of cellulose dry strength additives

Nanocellulose pilot
Demonstration factory of cellulose based dry strength additives

Transportable demonstration unit for production of dry strength additives: multi-fibrillated cellulose (MFC) and highly refined pulp. It is unique in that it enables mill trials under production conditions.

Testbeds in real life (TR)
Not applicable

Luis Carlos Felix Tapia

Forsknings- och utvecklingsingenjör
+46 10 228 44 86 Read more about Luis Carlos Felix
Profile image

Contact Luis Carlos Felix

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Off
Division: Division Bioeconomy

A transportable demonstration pilot has been developed and constructed to enable evaluation and development of micro-fibrillated cellulose (MFC) at an industrial scale. The unit contains two containers which connect to the pulp mill’s existing production processes. The containers are designed for maximal flexibility and a production of 100 kg MFC per hour. The equipment is fed with pre-refined pulp from the pulp mill and MFC is produced through a combination of mechanical and enzymatic pre-treatments after which it’s fed back in to the mill’s paper or board production lines.

This demonstration pilot facility is unique and one of its kind in the world. It is expected to increase the speed of implementation of MFC as a strength additive within the paper and board industry. So far (March 2018), it has achieved three successful trials at different mills around Europe.

Materials Pulp, paper and packaging
Bioeconomy Packaging Pulp and paper
BioInnovation
2017
Pulp and paper Sekundär områdes navigation:
Circular transition
Production and manufacturing
Biotechnology
Biobased materials

Nanometrology Methods for Magnetic Nanoparticles

NanoMag
NanoMag

The objectives of the EU financed NanoMag project were to standardize, improve and redefine analysing methods of magnetic nanoparticles. Using improved manufacturing technologies, synthesized magnetic nanoparticles with specific properties were analysed with a multitude of characterization techniques.

Coordination, R&D activities in AC susceptometry analysis, magnetic modelling, synthesis of magnetic nanoparticles, elemental analysis and standardization
Completed
Digital infrastructure Digitalisation Electronics Formulated products Pharmaceuticals Material transition Generic metrology and measurement technology
Region Stockholm Västra Götaland Region
From Nov. 2013 to Nov. 2017
120 MSEK
Division: Division Materials and Industry

Aim and goal
•    Identify analysis techniques to be used as standardization measurements in the field of magnetic nanoparticle research and development
•    Use new or improved analysis techniques to control the properties of magnetic nanoparticles
•    Promote the standardization techniques so they can be used both in research and in industry
•    Provide/enable a traceable route for novel characterization techniques towards the basis of new metrological standards

Challenge
•    Correlate magnetic and structural properties of magnetic nanoparticles
•    Develop analysis techniques and models in the field of magnetic nanoparticles
•    Improve traceability of the magnetic nanoparticle “life time” from manufacturing to a specific application
•    Present standardized procedures for manufacturing of magnetic nanoparticles with specific properties

Solution
The NanoMag project gathered Europe’s leading experts within research institutes, companies, universities and metrology institutes, all carrying out front end research and developing applications in the field of magnetic nanoparticles. Most all of existing analysing techniques for magnetic nanoparticles were used in the project.

Effect
The NanoMag results define standard measurements which are necessary for defining a magnetic nanoparticle system and for quality control. The result will provide valuables tools to the manufacturing process and the regulatory work on magnetic nanoparticles. The application areas of magnetic nanoparticles in the NanoMag project are focused on biomedical applications, for instance biosensing, contrast substances in medical tomography methods and for cancer therapy.

Christer Johansson

Senior Expert
+46 72 723 33 21 Read more about Christer
Profile image

Contact Christer

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
RISE University College London Uppsala University The Spanish National Research Council (CSIC) micromod Partikeltechnologie GmbH Technical University of Denmark University of Cantabria Chalmers University of Technology Federal Institute of Materials Research and Testing (BAM) Technical University of Braunschweig nanoPET Pharma GmbH Solve Research & Consultancy AB University of Lübeck Eindhoven University of Technology The Physikalisch Technische Bundesanstalt (PTB) National Physical Laboratory (NPL)
Project end date: Metrology Sekundär områdes navigation:
Medtech
Biotechnology
Composites